Expanding the Clinical Spectrum of DRP2-Associated Charcot-Marie-Tooth Disease
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Pelayo-Negro, AL
- Jerico, I
- Domínguez-González, C
- Horga, A
- De Rivera, FJR
- Gallardo, E
- Bermejo-Guerrero, L
- Lorz, MIP
- Cordoba, M
- Fenollar-Cortés, MD
- Espinós, C
- Apellániz-Ruiz, M
Grupos
Abstract
Background and Objectives Germline truncating variants in the DRP2 gene (encoding dystrophin-related protein 2) cause the disruption of the periaxin-DRP2-dystroglycan complex and have been linked to Charcot-Marie-Tooth disease. However, the causality and the underlying phenotype of the genetic alterations are not clearly defined. Methods This cross-sectional retrospective observational study includes 9 patients with Charcot-Marie-Tooth disease (CMT) with DRP2 germline variants evaluated at 6 centers throughout Spain. Results We identified 7 Spanish families with 4 different DRP2 likely pathogenic germline variants. In agreement with an X-linked inheritance, men harboring hemizygous DRP2 variants presented with an intermediate form of CMT, whereas heterozygous women were asymptomatic. Symptom onset was variable (36.6 +/- 16 years), with lower limb weakness and multimodal sensory loss producing a mild-to-moderate functional impairment. Nerve echography revealed an increase in the cross-sectional area of nerve roots and proximal nerves. Lower limb muscle magnetic resonance imaging confirmed the presence of a length-dependent fatty infiltration. Immunostaining in intradermal nerve fibers demonstrated the absence of DRP2 and electron microscopy revealed abnormal myelin thickness that was also detectable in the sural nerve sections. Discussion Our findings support the causality of DRP2 pathogenic germline variants in CMT and further define the phenotype as a late-onset sensory and motor length-dependent neuropathy, with intermediate velocities and thickening of proximal nerve segments.
Datos de la publicación
- ISSN/ISSNe:
- 0028-3878, 1526-632X
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 38513194
- Factor de Impacto:
- 2,587 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
NEUROLOGY LIPPINCOTT WILLIAMS & WILKINS
Citas Recibidas en Web of Science: 3
Documentos
- No hay documentos
Filiaciones
Campos de Estudio
Proyectos y Estudios Clínicos
Caracterizacion genotipica y fenotipica en una serie de pacientes con neuropatias hereditarias de inicio tardio.
Investigador Principal: TERESA SEVILLA MANTECÓN
PI19/01178 . INSTITUTO DE SALUD CARLOS III . 2020
Clinical studies, genetic basis and prognosis biomarkers in rare neurodegenerative diseases.
Investigador Principal: LUÍS BATALLER ALBEROLA
PI21/00103 . INSTITUTO DE SALUD CARLOS III . 2022
Profundizando en el diagnóstico genético de neuropatías hereditarias mediante técnicas de secuenciación completa de genoma
Investigador Principal: RAFAEL SIVERA MASCARÓ
PI22/01830 . INSTITUTO DE SALUD CARLOS III . 2023
Cita
SIVERA R,Pelayo AL,Jerico I,Domínguez C,Horga A,De Rivera FJR,Gallardo E,TEMBL JI,Bermejo L,Lorz M,AZORIN I,Cordoba M,Fenollar MD,MILLET E,VILCHEZ JJ,Espinós C,Apellániz M,SEVILLA T. Expanding the Clinical Spectrum of DRP2-Associated Charcot-Marie-Tooth Disease. Neurology. 2024. 102. (7):e209174. IF:9,000. (1).
Portal de investigación